Respiratory fluoroquinolones: Differences in the details [1] (multiple letters)

Clinical Infectious Diseases

Volumn 38, Issue 9, 2004, Pages 1331-1333

  Mandell, L A ^a   Iannini, P B ^b   Tillotson, G S ^c   Saravolatz, Louis D ^d,f   Leggett, James E ^e  

^a MCMASTER UNIVERSITY   (Canada)

^b DANBURY HOSPITAL   (United States)

^c PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; GATIFLOXACIN; GEMIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TROVAFLOXACIN; ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ANALYTIC METHOD; ANTIBACTERIAL ACTIVITY; BACTERIAL GENE; BACTERIUM ISOLATE; CHRONIC BRONCHITIS; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; DISEASE EXACERBATION; DRUG MECHANISM; DRUG RESEARCH; DRUG RESPONSE; EOSINOPHILIC DERMATOSIS; HUMAN; IN VITRO STUDY; LETTER; NONHUMAN; PHARMACEUTICAL CARE; PRIORITY JOURNAL; RASH; SKIN DISEASE; STEVENS JOHNSON SYNDROME; STREPTOCOCCUS PNEUMONIAE; TOXIC EPIDERMAL NECROLYSIS; ADULT; ANTIBIOTIC RESISTANCE; CHEMICALLY INDUCED DISORDER; COMMUNICABLE DISEASE; FEMALE; MALE; NOTE; RESPIRATORY TRACT INFECTION;

ADULT; ANTI-INFECTIVE AGENTS; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; EXANTHEMA; FEMALE; FLUOROQUINOLONES; HUMANS; MALE; RESPIRATORY TRACT INFECTIONS;

EID: 2342469318     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/383153     Document Type: Letter

References (0)